<?xml version="1.0"?>

<document>
	<title>Evaluation of the safety of amantadine-HC1 and the role of
   respiratory viral infections in children with cystic fibrosis.</title>

	<author>Wright-P-F.</author>
	<author>Khaw-K-T.</author>
	<author>Oxman-M-N.</author>
	<author>Shwachman-H.</author>

	<source>J-Infect-Dis. 1976 Aug. 134(2). P 144-9.</source>

	<abstract>Amantadine-HC1, an antiviral drug clinically effective against most
   strains of influenza A virus, was evaluated in a double-blind trial
   in 153 children with cystic fibrosis during the initial appearance of
   influenza A/England/42 virus in the New England area. Infection with
   this variant strain of influenza virus did not reach epidemic
   proportions during the study, so that the effectiveness of amantadine
   in this study population could not be fully assessed. However, the
   potential symptomatic and biochemical toxicity of amantadine was
   carefully monitored in a pediatric population. Serologic screening by
   complement fixation tests indicated that respiratory viruses may be
   important pathogens in exacerbations of respiratory disease in
   patients with cystic fibrosis.</abstract>

	<majorsubject>AMANTADINE: tu</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: co</majorsubject>
	<majorsubject>INFLUENZA: pc</majorsubject>
	<majorsubject>RESPIRATORY-TRACT-INFECTIONS: pc</majorsubject>
	<majorsubject>VIRUS-DISEASES: pc</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>AMANTADINE: ae</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>CLINICAL-TRIALS</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>INFANT</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PLACEBOS</minorsubject>
	<minorsubject>RESPIRATORY-TRACT-INFECTIONS: et</minorsubject>
	<minorsubject>SUPPORT-U-S-GOVT-P-H-S</minorsubject>
	<minorsubject>VIRUS-DISEASES: et</minorsubject>

	<reference>001   DAVIES WL             SCIENCE                        144   862 964</reference>
	<reference>002   TOGO Y                JAMA                           203  1089 968</reference>
	<reference>003   SMORODINSTSEV AA      JAMA                           213  1448 970</reference>
	<reference>004   WINGFIELD WL          N ENGL J MED                   281   579 969</reference>
	<reference>005   ANON                  AAP COMMITTEE INFECT DIS REPT        140 974</reference>
	<reference>006   QUILLIGAN JJ JR       J PEDIATR                       69   572 969</reference>
	<reference>007   ANON                  RECOMMENDED METHOD FOR THE US            971</reference>
	<reference>008   SEVER JL              J IMMUNOL                       88   320 962</reference>
	<reference>009   BIANDRATE P           J CHROMATOGR                    74    31 972</reference>
	<reference>010   ANON                  INFLUENZA RESPIRATORY DISEASE            974</reference>
	<reference>011   KATTWINKEL J          J PEDIATR                       82   234 973</reference>
	<reference>012   BLEIDNER WE           J PHARMACOL EXP THER           150   484 965</reference>
	<reference>013   MCLAREN C             LANCET                           1  1157 973</reference>
	<reference>014   CHANOCK RM            JAMA                           176   647 961</reference>

	<citation>1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977</citation>
	<citation>2   TERMEULEN V           MONATSSCHR KINDERHEILKD        127   367 979</citation>
	<citation>3   GLEZEN WP             REV INFECT DIS                   2   408 980</citation>
	<citation>4   BECKER Y              PROG MED VIROL                  26     1 980</citation>
	<citation>5   FISHAUT M             AM J DIS CHILD                 134   321 980</citation>
	<citation>6   FEIGELSON J           NOUV PRESSE MED                 10   955 981</citation>
	<citation>7   HALL CB               AM J MED                        70   670 981</citation>
	<citation>8   PETERSEN NT           ACTA PAEDIATR SCAND             70   623 981</citation>
	<citation>9   GLEZEN WP             PEDIATR RES                     17  1029 983</citation>
	<citation>10   AMBROSINI PJ          J CLIN PSYCHOPHARMACOL           4   223 984</citation>
	<citation>11   EFTHIMIOU J           THORAX                          39   150 984</citation>
	<citation>12   WANG EEL              N ENGL J MED                   311  1653 984</citation>
	<citation>13   MISCHLER EH           SEM RESPIR MED                   6   271 985</citation>
	<citation>14   SHIELDS WD            NEUROLOGY                       35   579 985</citation>
	<citation>15   FRIEND PA             J INFECT                        13    55 986</citation>
	<citation>16   STROOBANT J           J ROY SOC MED                   79    19 986</citation>
	<citation>17   WANG EEL              PEDIATR INFECT DIS J             6   256 987</citation>
	<citation>18   THOMPSON J            J MED VIROL                     21   249 987</citation>

</document>
